Literature DB >> 23622421

Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease.

Jorge Padilla-Ibarra, Adriana Sanchez-Ortiz, Carlos Sandoval-Castro, Cesar Ramos-Remus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23622421

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

1.  Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.

Authors:  Roham T Zamanian; David Badesch; Lorinda Chung; Robyn T Domsic; Thomas Medsger; Ashley Pinckney; Lynette Keyes-Elstein; Carla D'Aveta; Meagan Spychala; R James White; Paul M Hassoun; Fernando Torres; Andrew J Sweatt; Jerry A Molitor; Dinesh Khanna; Holden Maecker; Beverly Welch; Ellen Goldmuntz; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2021-07-15       Impact factor: 30.528

Review 2.  Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.

Authors:  Mathieu Gerfaud-Valentin; Vincent Cottin; Yvan Jamilloux; Arnaud Hot; Agathe Gaillard-Coadon; Isabelle Durieu; Christiane Broussolle; Jean Iwaz; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease.

Authors:  Grant H Lowther; Jason Chertoff; Jessica Cope; Hassan Alnuaimat; Ali Ataya
Journal:  Pulm Circ       Date:  2017-06-06       Impact factor: 3.017

4.  Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Authors:  François Vercruysse; Thomas Barnetche; Estibaliz Lazaro; Emilie Shipley; François Lifermann; Alexandre Balageas; Xavier Delbrel; Bruno Fautrel; Christophe Richez; Thierry Schaeverbeke; Marie-Elise Truchetet
Journal:  Arthritis Res Ther       Date:  2019-02-12       Impact factor: 5.156

Review 5.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

6.  Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report.

Authors:  Furong Zeng; Guangtong Deng; Hui Luo; Xiaoxia Zuo; Yanli Xie
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.